About Us

Dr. Leo Nissola

Dr. Nissola has designed, authored and conducted Phase I andII clinical programs, taking impossible ideas and thought-provokingbreakthrough science into clinical development plans —leading complex,adaptive, multi-stage, and platform studies for oncology and immunotherapy inthe United States.

Dr. Nissola leads our targeted research efforts globally, attending to high-stake situations in life sciences.
His clinical studies evaluated experimental cancer treatments, novel drugcombinations, molecules, and DNA-based vaccines in leading academicinstitutions in the United States through his work at The Parker Institute forCancer Immunotherapy and fellowship at MD Anderson Cancer Center.

Dr. Nissola’s studies evaluated human health, clinical data, and the safetyrisks associated with drugs, devices, and biological materials.
Dr. Nissola has been endorsed by Nobel Prize Laureates and is frequentlyfeatured as a medical expert on BBC, CBS, FOX, MSNBC, NBC, and other networks. Dr. Nissola built, evaluated, and designed data-drivenCOVID-19 epidemiological models, some of which were featured by the White Housein Press Briefings.

He is a former University of Texas MD Anderson Cancer Center Medical OncologyResearch Fellow and has previously led multi-billion-dollar drug assets atleading biotechnology and multinational pharmaceutical companies.

Dr. Nissola is a first-generation American immigrant from Brazil. He is a former intern at the prestigious First Faculty of Medicine at CharlesUniversity in Prague, founded in 1348, the oldest medical faculty in Central Europe and the 11th oldest medical institution in the world, regularly ranked in the top 1% of medical faculties globally.

This fellowship has never been awarded to any other Brazilian national inhistory. He is a twice-published book author and an advocate for inclusive public health policies and ending LGBTQ conversion therapy experiments.

He is the author of the best-selling The Immunity Solution book at W.W. Norton and a the ChiefScientific Officer of FIRSTBIO Research, a scientific advisory firm based inCalifornia with a global reach.

Our design approach prioritizes the needs and preferences of users. We focus on creating products that enhance the user experience, ensuring that they are both functional and enjoyable to use.